ArticleAfrican journal of emergency medicine : Revue africaine de la medecine d'urgence2025
Alphachloralose intoxication: A retrospective study on epidemiology, clinical presentation, and management in an adult emergency department in Morocco.
Article in African journal of emergency medicine : Revue africaine de la medecine d'urgence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Alphachloralose, initially used as a hypnotic and anesthetic, is now restricted to rodenticides. Despite limited medical use, it remains accessible in North Africa, contributing to intentional poisonings. Poisoning primarily presents with neurological and respiratory symptoms, posing a significant public health concern. This study describes the epidemiological, clinical, and therapeutic characteristics of alphachloralose poisoning cases admitted to the adult emergency department of a university hospital in Casablanca, Morocco. Methods: A retrospective study analyzed emergency department records for alphachloralose poisoning cases from October 2022 to June 2023. Poisoning was confirmed based on clinical presentation, witness accounts, and/or biological toxicological evidence. Data on demographics, exposure circumstances, clinical features, interventions, and outcomes were extracted. Severity was evaluated using the Poisoning Severity Score (PSS), grading the severity into five levels from 0 (no symptoms) to 4 (fatal). Hospital stay duration and complications were also assessed. Results: Some 53 cases were included, with mean age of patients 27 years, and a male-to-female ratio of 0.83. Suicidal ingestion accounted for the vast majority of cases (98 %). Alphachloralose was exclusively ingested in powdered form, as no other formulations are available in Morocco. Neurological and respiratory disturbances were the most common clinical manifestations, with 28 % of cases classified as severe according to the PSS. Gastric lavage was performed in 52.8 % of cases, benzodiazepines were administered in 54 %, and 39.6 % of patients required intubation. The median time to admission to intensive care was 5 h. The average duration of hospitalization was 2.4 ± 1.2 days. Although one fatality occurred, 98 % of cases recovered fully without complications, emphasizing the importance of early and appropriate management. Conclusion: Alphachloralose poisoning is a significant toxicological concern in North Africa due to its availability and misuse. Severe symptoms are frequent, but early intervention leads to favorable outcomes. Public health measures focusing on regulation and education are essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.